USNU Financial Statements From 2010 to 2025

USNUDelisted Stock  USD 1.38  0.00  0.00%   
Analyzing historical trends in various income statement and balance sheet accounts from US NeuroSurgical's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting US NeuroSurgical's valuation are summarized below:
US NeuroSurgical Holdings does not at this time have any fundamental measures for analysis.
Check US NeuroSurgical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among US NeuroSurgical's main balance sheet or income statement drivers, such as , as well as many indicators such as . USNU financial statements analysis is a perfect complement when working with US NeuroSurgical Valuation or Volatility modules.
  
This module can also supplement various US NeuroSurgical Technical models . Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

US NeuroSurgical Holdings Company Return On Equity Analysis

US NeuroSurgical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current US NeuroSurgical Return On Equity

    
  -1.18  
Most of US NeuroSurgical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, US NeuroSurgical Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, US NeuroSurgical Holdings has a Return On Equity of -1.1813. This is 95.07% lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.

US NeuroSurgical Holdings Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining US NeuroSurgical's current stock value. Our valuation model uses many indicators to compare US NeuroSurgical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across US NeuroSurgical competition to find correlations between indicators driving US NeuroSurgical's intrinsic value. More Info.
US NeuroSurgical Holdings is rated fourth in return on equity category among its peers. It is rated first in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the US NeuroSurgical's earnings, one of the primary drivers of an investment's value.

About US NeuroSurgical Financial Statements

US NeuroSurgical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although US NeuroSurgical investors may analyze each financial statement separately, they are all interrelated. The changes in US NeuroSurgical's assets and liabilities, for example, are also reflected in the revenues and expenses on on US NeuroSurgical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
NeuroSurgical Holdings, Inc., through its subsidiaries, owns and operates stereotactic radiosurgery centers that utilize gamma knife technology. NeuroSurgical Holdings, Inc. was founded in 1993 and is based in Rockville, Maryland. US Neurosurgical operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 3 people.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Consideration for investing in USNU Pink Sheet

If you are still planning to invest in US NeuroSurgical Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the US NeuroSurgical's history and understand the potential risks before investing.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing